Dear editor,


Faienza et al. measured serum irisin concentration in children and adult patients with Prader–Willi syndrome (PWS) [1]. By multiple regression analysis, serum irisin levels in pediatric and adult PWS could be predicted by the genetic background and 25(OH)-vitamin D levels. In addition, intelligent indicator was selected as a significant predictor of serum irisin in adult patients with PWS. I present information on the association between serum irisin, bone health and cognition.

By a randomized controlled trial with combination of exercise and vitamin D supplementation, inverse relationship between pro-inflammatory marker and serum irisin concentration became stronger [2]. According to a review by Zhong et al., regulation of bone cell metabolism by irisin might be accelerated by exercise and vitamin D [3].

Conti et al. measured serum irisin and brain-derived neurotrophic factor (BDNF) in patients with Alzheimer's disease (AD) [4]. Mean serum irisin concentration was significantly elevated in patients with agitation/aggression (AA), and it correlated with the duration of AA. In contrast, there was no significant change in serum BDNF. They considered that serum irisin concentration might reflect the clinical status of AD in relation to aberrant motor behavior.

Among several biological action of circulating irisin, I suppose that changes in bone metabolism and cognition may be related in older subjects, and comprehensive studies are needed to verify the inter-relationship among bone metabolism, cognition and serum irisin concentration.